Dosimetry of (177)Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol

Radio-ligand therapy (RLT) with(177)Lu-PSMA-617 is a promising option for patients with metastatic castration-resistant prostate-cancer (mCRPC). A prospective phase-II study (EUDRACT/RSO,2016-002732-32) on mCRPC is ongoing at IRST (Meldola, Italy). A total of 9 patients (median age: 68 y, range: 53–...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarnelli, Anna, Belli, Maria Luisa, Di Iorio, Valentina, Mezzenga, Emilio, Celli, Monica, Severi, Stefano, Tardelli, Elisa, Nicolini, Silvia, Oboldi, Devil, Uccelli, Licia, Cittanti, Corrado, Monti, Manuela, Ferrari, Mahila, Paganelli, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385027/
https://www.ncbi.nlm.nih.gov/pubmed/30754620
http://dx.doi.org/10.3390/molecules24030621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385027/
https://www.ncbi.nlm.nih.gov/pubmed/30754620
http://dx.doi.org/10.3390/molecules24030621

Ejemplares similares